NuVasive Total Assets 2006-2019 | NUVA

NuVasive total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
NuVasive Annual Total Assets
(Millions of US $)
2018 $1,708
2017 $1,640
2016 $1,571
2015 $1,303
2014 $1,342
2013 $1,180
2012 $1,164
2011 $1,124
2010 $802
2009 $653
2008 $487
2007 $226
2006 $196
2005 $71
NuVasive Quarterly Total Assets
(Millions of US $)
Q3 2019 $1,840
Q2 2019 $1,805
Q1 2019 $1,751
Q4 2018 $1,708
Q3 2018 $1,675
Q2 2018 $1,672
Q1 2018 $1,671
Q4 2017 $1,640
Q3 2017 $1,629
Q2 2017 $1,606
Q1 2017 $1,570
Q4 2016 $1,571
Q3 2016 $1,636
Q2 2016 $1,606
Q1 2016 $1,569
Q4 2015 $1,303
Q3 2015 $1,272
Q2 2015 $1,286
Q1 2015 $1,296
Q4 2014 $1,342
Q3 2014 $1,269
Q2 2014 $1,254
Q1 2014 $1,225
Q4 2013 $1,180
Q3 2013 $1,140
Q2 2013 $1,108
Q1 2013 $1,101
Q4 2012 $1,164
Q3 2012 $1,185
Q2 2012 $1,167
Q1 2012 $1,149
Q4 2011 $1,124
Q3 2011 $1,115
Q2 2011 $1,273
Q1 2011 $807
Q4 2010 $802
Q3 2010 $711
Q2 2010 $686
Q1 2010 $666
Q4 2009 $653
Q3 2009 $633
Q2 2009 $599
Q1 2009 $525
Q4 2008 $487
Q3 2008 $469
Q2 2008 $453
Q1 2008 $447
Q4 2007 $226
Q3 2007 $216
Q2 2007 $210
Q1 2007 $207
Q4 2006 $196
Q3 2006 $194
Q2 2006 $208
Q1 2006 $210
Q4 2005 $71
Q3 2005 $74
Q2 2005 $83
Q1 2005 $80
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.069B $1.102B
NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $159.746B 22.07
Abbott Laboratories (ABT) United States $158.348B 27.64
Stryker (SYK) United States $80.133B 25.93
Boston Scientific (BSX) United States $60.562B 28.59
Baxter (BAX) United States $46.231B 28.03
EssilorLuxottica Societe Anonyme (ESLOY) France $33.127B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.688B 19.25
Lonza Group Ag (LZAGY) Switzerland $30.435B 0.00
Terumo (TRUMY) Japan $27.571B 34.41
Coloplast (CLPBY) Denmark $27.108B 41.83
ResMed (RMD) United States $23.480B 43.32
Smith & Nephew SNATS (SNN) United Kingdom $21.662B 0.00
Sunny Optical Technology (SNPTF) China $18.679B 0.00
Insulet (PODD) United States $11.963B 569.15
Bio-Rad Laboratories (BIO) United States $10.985B 52.73
Canopy Growth (CGC) Canada $8.357B 0.00
Perrigo (PRGO) Ireland $8.101B 15.11
William Demant Holdings (WILYY) Denmark $7.896B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
Hill-Rom Holdings (HRC) United States $7.251B 20.86
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.459B 36.89
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $3.868B 25.21
Neogen (NEOG) United States $3.618B 60.20
GW Pharmaceuticals (GWPH) United Kingdom $3.508B 0.00
Quidel (QDEL) United States $3.312B 31.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.221B 0.00
Agios Pharmaceuticals (AGIO) United States $3.095B 0.00
National Vision Holdings (EYE) United States $2.838B 64.05
Aurora Cannabis (ACB) Canada $2.301B 0.00
Cardiovascular Systems (CSII) United States $1.759B 0.00
AtriCure (ATRC) United States $1.547B 0.00
InMode (INMD) Israel $1.511B 0.00
TG Therapeutics (TGTX) United States $1.408B 0.00
Aphria (APHA) $1.263B 0.00
VAREX IMAGING (VREX) United States $1.166B 23.29
Phibro Animal Health (PAHC) United States $1.052B 19.70
NanoString Technologies (NSTG) United States $1.015B 0.00
PetIQ (PETQ) United States $0.857B 20.90
Eagle Pharmaceuticals (EGRX) United States $0.776B 29.71
Quanterix (QTRX) United States $0.761B 0.00
LeMaitre Vascular (LMAT) United States $0.734B 41.25
Lantheus Holdings (LNTH) United States $0.713B 17.81
Omeros (OMER) United States $0.683B 0.00
Cerus (CERS) United States $0.582B 0.00
Surmodics (SRDX) United States $0.538B 55.78
MacroGenics (MGNX) United States $0.511B 0.00
OraSure Technologies (OSUR) United States $0.472B 28.33
Organigram Holdings (OGI) Canada $0.444B 0.00
Meridian Bioscience (VIVO) United States $0.441B 15.13
Owens & Minor (OMI) United States $0.418B 15.47
Utah Medical Products (UTMD) United States $0.392B 28.39
HEXO (HEXO) $0.375B 0.00
Zynex (ZYXI) United States $0.344B 38.89
BioLife Solutions (BLFS) United States $0.306B 124.75
Bovie Medical (APYX) United States $0.264B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Repro-Med Systems (KRMD) United States $0.237B 0.00
Vapotherm (VAPO) United States $0.229B 0.00
United Health Products (UEEC) United States $0.221B 0.00
Female Health (VERU) United States $0.217B 0.00
Viemed Healthcare (VMD) United States $0.216B 22.76
Liberty Health Sciences (LHSIF) Canada $0.182B 0.00
Rockwell Medical (RMTI) United States $0.176B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.173B 0.00
InfuSystems Holdings (INFU) United States $0.168B 849.00
Cytosorbents (CTSO) United States $0.153B 0.00
Fonar (FONR) United States $0.135B 9.51
Chimerix (CMRX) United States $0.111B 0.00
MTech Acquisition (KERN) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.081B 20.41
MRI Interventions (MRIC) United States $0.079B 0.00
Nephros (NEPH) United States $0.075B 0.00
Surface Oncology (SURF) United States $0.074B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) $0.048B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.026B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00